FTC's Antitrust Suit Against Cephalon Moved To Pa.
A lawsuit by the U.S. Federal Trade Commission alleging that Cephalon Inc. paid off would-be competitors in the market for its narcolepsy drug Provigil will be heard in Pennsylvania, over the...To view the full article, register now.
Already a subscriber? Click here to view full article